VITEK COMPACT PRO receives FDA 510(k) Clearance
bioMérieux has received FDA 510(k) clearance for VITEK COMPACT PRO, aimed at improving diagnostics in clinical and industrial laboratories.
Tag: bioMérieux
All
Latest
All
Latest
bioMérieux Gets CE marking for NephroCheck Test on Vidas
The NephroCheck test relies on the detection of two urinary biomarkers: TIMP-2 and IGFBP-7. Both are produced by stressed kidney cells before the onset of AKI.
All
Latest
BioMérieux Recalls Vitek 2 Gram-Positive Antimicrobial Susceptibility Testing Cards
The Class I recall includes all lots of gram-positive AST cards with cefoxitin and oxacillin tests; use of the devices may cause serious injury or death.
Antibiotic Resistance: A National Strategy
The federal plan to combat and prevent highly resistant bacteria anticipates a stronger role for diagnostic testing and laboratory surveillance.
Read More
bioMérieux Breaks Ground on New Production Line at Durham Facility
bioMerieux sepsis facility expansion will help address the global public health threat of sepsis and meet the related demand for microbial detection.
Read More
Stefan Willemsen Named President and CEO of bioMérieux Inc
In vitro diagnostics manufacturer bioMérieux has appointed Stefan Willemsen, MA, as president and CEO of bioMérieux Inc. He will lead the company’s operations in its recently created North and Latin America region.
Read More